Biochemical Reagent
-
BA6620 NavocaftorSummary: Navocaftor (GLPG3067) as a cystic fibrosis transmembrane modulator. -
BA6621 CavosonstatSummary: Cavosonstat (N91115) is an orally active inhibitor. -
BA6622 GalicaftorSummary: An effective, orally active transmembrane conductance modulator corrector for cystic fibrosis -
BA6623 SRI-37240Summary: SRI-37240 is a potent early termination codon inhibitor. -
BA6624 IcenticaftorSummary: Icenticaftor (QBW251) is an orally active channel enhancer. -
BA6625 NJH-2-056Summary: NJH-2-056 is a deubiquitinase-targeting chimera with linked recruitment factor EN523 and chaperone protein lumacaftor. -
BA6626 KobusinSummary: Kobusin was isolated from a double epoxy lignan. -
BA6627 UCCF-853Summary: A regulator. -
BA6628 VRT-532Summary: VRT-532 (CFpot-532) is an effective regulator. -
BA6629 Corr4ASummary: Corr4A is a chemical corrective agent that can be used to treat cystic fibrosis.

